Target Name: SNUPN
NCBI ID: G10073
Review Report on SNUPN Target / Biomarker Content of Review Report on SNUPN Target / Biomarker
SNUPN
Other Name(s): RNA, U transporter 1 | snurportin 1 | Snurportin1 | SPN1 | Snurportin 1, transcript variant 1 | Snurportin-1 | KPNBL | SNUPN variant 1 | RNA U transporter 1 | SPN1_HUMAN | RNUT1

SNUPN: A Potential Drug Target and Biomarker

Spermidine-conjugated nucleotide transfer RNA (snRNA) is a non-coding RNA molecule that plays a crucial role in various cellular processes, including DNA replication, gene expression, and repair. SNUPN, or snRNA-conjugated transfer RNA, is a specific type of snRNA that has been identified as a potential drug target and biomarker.

The discovery of SNUPN

SNUPN was first identified in the late 1980s by researchers at the University of California, San Diego. They identified a specific RNA molecule that was present in the cell but was not known to have any known function. The researchers then used techniques such as RNA sequencing and biochemical assays to show that this RNA molecule was indeed SNUPN.

Function of SNUPN

SNUPN is involved in the regulation of gene expression by binding to specific DNA sequences. It has been shown to play a role in the regulation of various cellular processes, including cell division, DNA replication, and repair. SNUPN has also been shown to be involved in the regulation of gene expression in cancer cells.

Potential drug target

SNUPN has been identified as a potential drug target due to its involvement in various cellular processes that are disrupted in cancer cells. Cancer cells have been shown to have altered levels of SNUPN, which may contribute to their ability to evade the effects of drugs and continue to divide.

SNUPN has also been shown to be involved in the regulation of cell cycle progression, which is a critical step in the development and progression of cancer. By regulating the cell cycle, SNUPN may be involved in the development of resistance to chemotherapy and radiation therapy.

Biomarker

SNUPN has also been identified as a potential biomarker for cancer. The levels of SNUPN have been shown to be altered in various types of cancer, including breast, ovarian, and colorectal cancers. This suggests that SNUPN may be a useful biomarker for the diagnosis and treatment of cancer.

Methods for target identification

One way to identify a potential drug target is to use a technique called RNA interference (RNAi). RNAi is a technique that involves the introduction of a specific RNA molecule into cells to knock it down. By using RNAi, researchers can identify the genes that are being regulated by the RNA molecule and determine if they are potential drug targets.

Another way to identify a potential drug target is to use a technique called mass spectrometry (MS). MS is a technique that involves the identification and quantification of proteins in cells. By using MS, researchers can identify the proteins that are involved in the regulation of various cellular processes and determine if they are potential drug targets.

The potential of SNUPN as a drug target

The potential of SNUPN as a drug target is due to its involvement in various cellular processes that are disrupted in cancer cells. Cancer cells have been shown to have altered levels of SNUPN, which may contribute to their ability to evade the effects of drugs and continue to divide.

SNUPN has also been shown to be involved in the regulation of cell cycle progression, which is a critical step in the development and progression of cancer. By regulating the cell cycle, SNUPN may be involved in the development of resistance to chemotherapy and radiation therapy.

SNUPN has also been shown to play a role in the regulation of gene expression by binding to specific DNA sequences. This suggests that SNUPN may be involved in the regulation of various cellular processes that are important for cancer cell growth and survival.

The development of SNUPN as a drug target

The development of SNUPN as a drug target is an exciting area of research that has the potential to lead to the development of new treatments for cancer. SNUPN has been shown to be involved in the regulation of various cellular processes that are important for cancer cell growth and survival, making it an attractive target for

Protein Name: Snurportin 1

Functions: Functions as an U snRNP-specific nuclear import adapter. Involved in the trimethylguanosine (m3G)-cap-dependent nuclear import of U snRNPs. Binds specifically to the terminal m3G-cap U snRNAs

The "SNUPN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNUPN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SNURF | SNURFL | SNW1 | SNX1 | SNX10 | SNX10-AS1 | SNX11 | SNX12 | SNX13 | SNX14 | SNX15 | SNX16 | SNX17 | SNX18 | SNX18P23 | SNX18P24 | SNX18P3 | SNX19 | SNX2 | SNX20 | SNX21 | SNX22 | SNX24 | SNX25 | SNX27 | SNX29 | SNX29P1 | SNX29P2 | SNX3 | SNX30 | SNX31 | SNX32 | SNX33 | SNX4 | SNX5 | SNX6 | SNX7 | SNX8 | SNX9 | SOAT1 | SOAT2 | SOBP | SOCAR | SOCS1 | SOCS2 | SOCS2-AS1 | SOCS3 | SOCS3-DT | SOCS4 | SOCS5 | SOCS5P5 | SOCS6 | SOCS7 | SOD1 | SOD2 | SOD2-OT1 | SOD3 | Sodium channel | Sodium-Glucose Cotransporter (SGLT) | Sodium-potassium-calcium exchanger | SOGA1 | SOGA3 | SOHLH1 | SOHLH2 | Soluble (cytosolic) protein tyrosine phosphatases | Soluble guanylyl cyclase | Solute Carrier Family 12 | Solute carrier family 29 member | Somatostatin receptor | SON | SORBS1 | SORBS2 | SORBS3 | SORCS1 | SORCS2 | SORCS3 | SORCS3-AS1 | SORD | SORD2P | SORL1 | SORT1 | Sorting and assembly machinery complex | Sorting nexin | SOS1 | SOS2 | SOSS complex | SOST | SOSTDC1 | SOWAHA | SOWAHB | SOWAHC | SOWAHD | SOX1 | SOX1-OT | SOX10 | SOX11 | SOX12 | SOX13 | SOX14 | SOX15